Tamara Prodanov

1.8k total citations
30 papers, 917 citations indexed

About

Tamara Prodanov is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Tamara Prodanov has authored 30 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 27 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cancer Research. Recurrent topics in Tamara Prodanov's work include Adrenal and Paraganglionic Tumors (28 papers), Pituitary Gland Disorders and Treatments (19 papers) and Hormonal Regulation and Hypertension (18 papers). Tamara Prodanov is often cited by papers focused on Adrenal and Paraganglionic Tumors (28 papers), Pituitary Gland Disorders and Treatments (19 papers) and Hormonal Regulation and Hypertension (18 papers). Tamara Prodanov collaborates with scholars based in United States, Netherlands and Germany. Tamara Prodanov's co-authors include Karel Pacák, Electron Kebebew, Naris Nilubol, Tito Fojo, Dhaval Patel, Karen T. Adams, Constantine A. Stratakis, Robert Wesley, Karel Pacák and Victoria Martucci and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of Surgery.

In The Last Decade

Tamara Prodanov

29 papers receiving 910 citations

Peers

Tamara Prodanov
André Bonnin France
Katherine I. Wolf United States
A. H. J. T. Vriends Netherlands
L Billaud France
S K Grebe United States
Antônio Gonçalves de Oliveira-Filho Brazil
Antje Redlich Germany
Francisca Caimari Spain
Yun Mi Choi South Korea
Janet E. Dacie United Kingdom
André Bonnin France
Tamara Prodanov
Citations per year, relative to Tamara Prodanov Tamara Prodanov (= 1×) peers André Bonnin

Countries citing papers authored by Tamara Prodanov

Since Specialization
Citations

This map shows the geographic impact of Tamara Prodanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Prodanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Prodanov more than expected).

Fields of papers citing papers by Tamara Prodanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Prodanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Prodanov. The network helps show where Tamara Prodanov may publish in the future.

Co-authorship network of co-authors of Tamara Prodanov

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Prodanov. A scholar is included among the top collaborators of Tamara Prodanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Prodanov. Tamara Prodanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Mayank, Jorge A. Carrasquillo, Tamara Prodanov, et al.. (2024). Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma. Frontiers in Endocrinology. 15. 1399847–1399847. 1 indexed citations
2.
Jha, Abhishek, et al.. (2023). Paediatric phaeochromocytoma and paraganglioma: A clinical update. Clinical Endocrinology. 101(5). 446–454. 1 indexed citations
3.
Pamporaki, Christina, Tamara Prodanov, Leah Meuter, et al.. (2022). Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. European Journal of Cancer. 169. 32–41. 29 indexed citations
4.
Ghosal, Suman, Katerina Hadrava Vanova, Shaoli Das, et al.. (2022). Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis. Endocrine. 79(1). 171–179. 17 indexed citations
5.
Ghosal, Suman, Thanh‐Truc Huynh, Leah Meuter, et al.. (2021). A long noncoding RNA–microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas. Endocrine. 75(1). 244–253. 3 indexed citations
6.
Jochmanová, Ivana, Robert Wesley, Melissa Gonzales, et al.. (2020). Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents. Journal of Cancer Research and Clinical Oncology. 146(4). 1051–1063. 26 indexed citations
7.
Dmitriev, Pauline, Herui Wang, Jared S. Rosenblum, et al.. (2019). Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation Syndrome. JAMA Ophthalmology. 138(2). 148–148. 6 indexed citations
8.
Nockel, Pavel, Mustapha El Lakis, Apostolos Gaitanidis, et al.. (2017). Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 163(1). 191–196. 34 indexed citations
9.
Jochmanová, Ivana, Katherine I. Wolf, Kathryn S. King, et al.. (2017). SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlations. Journal of Cancer Research and Clinical Oncology. 143(8). 1421–1435. 53 indexed citations
10.
11.
Assadipour, Yasmine, Samira M. Sadowski, Meghna Alimchandani, et al.. (2016). SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Surgery. 161(1). 230–239. 54 indexed citations
12.
Ellis, Ryan J., Dhaval Patel, & Tamara Prodanov. (2014). The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas. Journal of Vascular Surgery. 60(3). 805–805. 2 indexed citations
13.
Vogel, Jennifer, Tamara Prodanov, Baris I. Turkbey, et al.. (2014). External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma. Frontiers in Oncology. 4. 166–166. 42 indexed citations
14.
Wesley, Robert, et al.. (2014). Clinical utility of chromogranin A in SDHx‐related paragangliomas. European Journal of Clinical Investigation. 44(4). 365–371. 29 indexed citations
15.
Ellis, Ryan J., Dhaval Patel, Tamara Prodanov, et al.. (2013). The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas. Annals of Surgery. 260(1). 158–162. 53 indexed citations
16.
Ellis, Ryan J., Dhaval Patel, Tamara Prodanov, et al.. (2013). Response after Surgical Resection of Metastatic Pheochromocytoma and Paraganglioma: Can Postoperative Biochemical Remission Be Predicted?. Journal of the American College of Surgeons. 217(3). 489–496. 28 indexed citations
17.
King, Kathryn S., Tamara Prodanov, Vitaly Kantorovich, et al.. (2011). Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB Mutations. Journal of Clinical Oncology. 29(31). 4137–4142. 131 indexed citations
18.
Lodish, Maya, Karen T. Adams, Tamara Prodanov, et al.. (2010). Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocrine Related Cancer. 17(3). 581–588. 23 indexed citations
19.
Prodanov, Tamara, Bas Havekes, Katherine L. Nathanson, Karen T. Adams, & Karel Pacák. (2009). Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?. Pediatric Nephrology. 24(6). 1239–1242. 14 indexed citations
20.
Popat, Vaishali, Tamara Prodanov, Karim A. Calis, & Lawrence M. Nelson. (2008). The Menstrual Cycle. Annals of the New York Academy of Sciences. 1135(1). 43–51. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Bonnin Breakdown of academic impact, for papers by Katherine I. Wolf Breakdown of academic impact, for papers by A. H. J. T. Vriends Breakdown of academic impact, for papers by L Billaud Breakdown of academic impact, for papers by S K Grebe Breakdown of academic impact, for papers by Antônio Gonçalves de Oliveira-Filho Breakdown of academic impact, for papers by Antje Redlich Breakdown of academic impact, for papers by Francisca Caimari Breakdown of academic impact, for papers by Yun Mi Choi Breakdown of academic impact, for papers by Janet E. Dacie
Rankless by CCL
2026